Trisenox arsenic trioxide regulatory update

CTIC said that the CPMP accepted for review its MAA for Trisenox to treat relapsed acute promyelocytic leukemia (APL). Trisenox is approved to treat relapsed or refractory APL in the U.S. and has Orp...